237 related articles for article (PubMed ID: 23050799)
1. Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.
Winter J; Pantelis A; Kraus D; Reckenbeil J; Reich R; Jepsen S; Fischer HP; Allam JP; Novak N; Wenghoefer M
BMC Cancer; 2012 Oct; 12():465. PubMed ID: 23050799
[TBL] [Abstract][Full Text] [Related]
2. 99mTcO4- accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors.
Akai A; Yamamura Y; Nonaka M; Yoshihara T
Auris Nasus Larynx; 2014 Dec; 41(6):532-8. PubMed ID: 25199743
[TBL] [Abstract][Full Text] [Related]
3. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
4. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
[TBL] [Abstract][Full Text] [Related]
6. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
7. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
Ashkavandi ZJ; Najvani AD; Tadbir AA; Pardis S; Ranjbar MA; Ashraf MJ
Asian Pac J Cancer Prev; 2013; 14(6):3479-82. PubMed ID: 23886132
[TBL] [Abstract][Full Text] [Related]
8. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.
Mannweiler S; Beham A; Langner C
APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551
[TBL] [Abstract][Full Text] [Related]
9. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
10. Nuclear hBD-1 accumulation in malignant salivary gland tumours.
Wenghoefer M; Pantelis A; Dommisch H; Götz W; Reich R; Bergé S; Martini M; Allam JP; Jepsen S; Merkelbach-Bruse S; Fischer HP; Novak N; Winter J
BMC Cancer; 2008 Oct; 8():290. PubMed ID: 18840281
[TBL] [Abstract][Full Text] [Related]
11. A microRNA signature for the differential diagnosis of salivary gland tumors.
Denaro M; Navari E; Ugolini C; Seccia V; Donati V; Casani AP; Basolo F
PLoS One; 2019; 14(1):e0210968. PubMed ID: 30682201
[TBL] [Abstract][Full Text] [Related]
12. Expression of ras-P21 in salivary gland tumors.
Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
[No Abstract] [Full Text] [Related]
13. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells.
Shrestha P; Sumitomo S; Ogata K; Yamada K; Takai Y; Yang L; Mori M
Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):393-9. PubMed ID: 7536507
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
17. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
[TBL] [Abstract][Full Text] [Related]
18. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
Nagel H; Laskawi R; Eiffert H; Schlott T
Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]